Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations

v3.3.1.900
Consolidated Statements of Operations - USD ($)
3 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Revenues $ 0 $ 0
Operating expenses:    
General and administrative expenses 865,512 870,355
Research and development expenses 414,003 399,735
Total operating expenses 1,279,515 1,270,090
Operating loss (1,279,515) (1,270,090)
Other income (expense):    
Interest expense (143,747) (27,765)
Gain on exercise of warrants and conversion of debt 129,461 224,000
Loss on warrant derivative modification 0 (1,300,170)
Decrease to fair value of derivative 137,146 2,753,170
Total other income 122,860 1,649,235
Net (loss) income $ (1,156,655) $ 379,145
Earnings per share - basic    
Net (loss) income per common share - basic $ (0.01) $ 0.01
Weighted common shares - basic 108,620,575 73,337,085
Earnings per share - diluted    
Net (loss) income per common share - diluted $ (0.01) $ 0.01
Weighted common shares - diluted 108,620,575 73,422,007